Linaclotide
Linaclotide is a prescription medication used to treat irritable bowel syndrome with constipation (IBS-C), chronic idiopathic constipation (CIC), and functional constipation (FC) in adults and certain children.
🧬 Where this information comes from Click to expand
The clinical label records used on this page are FDA-filed Structured Product Labeling (SPL) retrieved through openFDA. We identified 1 clinical label set within the page’s selected clinical scope after exact ingredient or ingredient-combination matching and applicable route/form matching. Forms, routes, brands, labelers, strengths, and NDC product-record counts are built separately from matching FDA National Drug Code Directory records. The linked DailyMed document is a representative official source for verification, not the page’s only clinical source. View the linked label on DailyMed →
Linaclotide (Linzess) treats IBS-C (irritable bowel syndrome with constipation) and ongoing constipation with no clear cause by drawing fluid into the intestine and, in IBS-C, calming pain-sensing gut nerves, with little reaching the bloodstream; on the market since about 2012, it is a familiar next step when fiber and over-the-counter laxatives fall short. Beyond the gut it causes few problems, but diarrhea is common, especially early on, and leads some people to stop, with gas, bloating and urgency close behind. The boxed warning forbids it in children under 2, since it caused fatal dehydration in newborn mice, so keep it far from toddlers.
Clinical pearls
- Take it on an empty stomach, at least 30 minutes before your first meal of the day, at about the same time daily.
- If capsules are hard to swallow, open one, mix the beads into applesauce or water, and swallow right away without chewing.
- If you miss a dose, skip it and take the next one at the usual time rather than doubling up.
- Severe diarrhea with dizziness, extreme thirst or little urine means stop it and call your prescriber right away for rehydration.
⚠️ FDA Boxed Warning — the FDA’s strongest safety alert ▾
Linzess must never be given to children under 2 years old. This is the FDA's most serious warning. In animal studies, linaclotide caused severe dehydration and death in newborns. The intestines of very young children react much more strongly to this drug, producing dangerous fluid loss. There is no safe dose for this age group. Keep Linzess out of reach of all young children, and never share it with anyone under 2.
Patient information guide A plain-language walkthrough of Linaclotide, written from its FDA label.
What Linaclotide is used for
▾
Linaclotide is approved for several types of constipation-related conditions. All approved forms in the U.S. are available as Linzess capsules taken by mouth.
- Irritable bowel syndrome with constipation (IBS-C) — Linzess is approved for adults and for children 7 years of age and older.
- Chronic idiopathic constipation (CIC) — Linzess is approved for adults only. "Idiopathic" means no identifiable underlying cause.
- Functional constipation (FC) — Linzess is approved for children 2 years of age and older.
How Linaclotide works
▾
Linaclotide activates a receptor on the surface of intestinal cells called guanylate cyclase-C (GC-C). When activated, GC-C triggers a rise in a signaling molecule called cGMP (cyclic guanosine monophosphate). This causes intestinal cells to secrete more chloride and bicarbonate into the gut, drawing water in, softening stool, and speeding up transit through the intestine. In IBS-C, linaclotide also appears to reduce visceral pain (pain felt deep in the belly) by lowering the activity of pain-sensing nerves — a separate benefit beyond just relieving constipation.
Linaclotide dosage
▾
Linzess is taken once daily by mouth, on an empty stomach, at least 30 minutes before your first meal — at roughly the same time every day. Do not crush or chew the capsules. If you miss a dose, skip it and take your next dose at the scheduled time; never take two doses at once.
- If you can't swallow capsules, the beads inside can be mixed with a small amount of room-temperature applesauce or water and swallowed right away.
- For patients with feeding tubes, a water-based method is available — follow your prescriber's specific instructions.
- Your prescriber will choose the right dose for your condition and age — follow their guidance exactly.
Dosing details from the FDA-approved label
From the Linaclotide prescribing information (“Dosage and Administration”). Doses are set by your prescriber for your product, condition, kidney function and age — never change a dose on your own.
- Irritable Bowel Syndrome with Constipation (IBS-C) in adults
- 290 mcg orally once daily
- Take on an empty stomach, at least 30 minutes prior to a meal at approximately the same time each day
- Irritable Bowel Syndrome with Constipation (IBS-C) in pediatric patients 7 years of age and older
- 145 mcg orally once daily
- Take on an empty stomach, at least 30 minutes prior to a meal at approximately the same time each day
- Chronic Idiopathic Constipation (CIC) in adults
- 145 mcg orally once daily
- A dosage of 72 mcg once daily may be used based on individual presentation or tolerability
- Take on an empty stomach, at least 30 minutes prior to a meal at approximately the same time each day
- Functional Constipation (FC) in pediatric patients 2 years of age and older
- 72 mcg orally once daily
- Take on an empty stomach, at least 30 minutes prior to a meal at approximately the same time each day
Read the label’s full dosing text
2 DOSAGE AND ADMINISTRATION The recommended dosage in adults is: IBS-C : 290 mcg orally once daily. ( 2.1 ) CIC : 145 mcg orally once daily or 72 mcg orally once daily based on individual presentation or tolerability. ( 2.1 ) The recommended dosage in pediatric patients: 7 years of age and older with IBS-C : 145 mcg orally once daily. ( 2.1 ) 2 years of age and older with FC : 72 mcg orally once daily. ( 2.1 ) Administration Instructions ( 2.2 ): Take on empty stomach at least 30 minutes prior to a meal at approximately the same time each day. Do not crush or chew LINZESS capsule or capsule contents. For patients who have difficulty swallowing capsules whole or those with a nasogastric or gastrostomy tube, see full prescribing information for instructions for opening the capsule and administering with applesauce or water. 2.1 Recommended Dosage Irritable Bowel Syndrome with Constipation (IBS-C) : The recommended dosage of LINZESS is: • Adults : 290 mcg orally once daily • Pediatric patients 7 years of age and older : 145 mcg orally once daily Chronic Idiopathic Constipation (CIC) in Adults The recommended dosage of LINZESS in adults is 145 mcg orally once daily. A dosage of 72 mcg once daily may be used based on individual presentation or tolerability. Functional Constipation (FC) in Pediatric Patients 2 Years of Age and Older The recommended dosage of LINZESS in pediatric patients 2 years of age and older is 72 mcg orally once daily. 2.2 Preparation and Administration Instructions • Take LINZESS on an empty stomach, at least 30 minutes prior to a meal at approximately the same time each day. • If a dose is missed, skip the missed dose and take the next dose at the regular time. Do not take 2 doses at the same time. • Do not crush or chew LINZESS capsule or capsule contents. • Swallow LINZESS capsule whole. • For patients who are unable to swallow the capsule whole, LINZESS capsules can be opened and administered orally in either applesauce or with water or administered with water via a nasogastric or gastrostomy tube. Sprinkling of LINZESS beads on other soft foods or in other liquids has not been tested. Oral Administration in Applesauce Place one teaspoonful of room-temperature applesauce into a clean container. Open the capsule. Sprinkle the entire contents (beads) on applesauce. Consume the entire contents immediately. Do not chew the beads.
Excerpted — the section continues on the label. Read the full Dosage and Administration section on DailyMed →
Linaclotide side effects
▾
The most common side effects of Linzess include:
Common side effects
- Diarrhea (the most common side effect)
- Abdominal pain or cramping
- Gas (flatulence)
- Abdominal bloating or distension
- Viral gastroenteritis (stomach bug)
- Headache
- Defecation urgency
- Fecal incontinence
- Diarrhea — by far the most frequent; usually starts within the first two weeks
When to get medical help
- Call your doctor right away if you develop severe or worsening diarrhea — it can lead to dangerous dehydration.
- Seek emergency help if a child under 2 years old is given this medication — it is not safe and can be fatal in this age group.
- Stop taking Linzess and contact your doctor if diarrhea causes signs of dehydration such as dizziness, decreased urination, or extreme thirst.
Severe diarrhea is the most important side effect to act on — if it's bad or doesn't let up, stop Linzess and call your doctor right away to avoid dangerous dehydration. Eating a high-fat meal close to your dose can also make diarrhea worse, so stick to taking it on an empty stomach.
Linaclotide warnings and precautions
▾
- Never give to children under 2: Linzess is contraindicated (not allowed) in this age group. It can cause rapid, life-threatening dehydration. This is the FDA's highest-level warning.
- Severe diarrhea: If you experience severe diarrhea, stop taking Linzess and contact your doctor immediately. You may need fluids to rehydrate.
- Mechanical gastrointestinal obstruction: Linzess must not be used if there is a known or suspected blockage in the gut — it could make the situation worse.
- Food timing matters: Taking Linzess right after a high-fat meal increases the chance of loose stools and more frequent bowel movements. Always take it on an empty stomach.
Linaclotide interactions
▾
Based on lab studies, linaclotide is not expected to interact with other medications in the typical way. It is minimally absorbed into the bloodstream and does not affect the liver enzymes (cytochrome P450 system) that process most drugs. However, the label notes that no formal drug interaction studies have been done in people.
- Food (especially high-fat meals): Taking Linzess right after a high-fat breakfast can increase loose stools and bowel frequency — always take on an empty stomach, 30 minutes before eating.
Not a complete list. The label covers the interactions the manufacturer studied or reported, and our own interaction database does not cover every medicine either. Bring your full medication list, including vitamins and herbal products, to your pharmacist.
Before taking Linaclotide
▾
- Children under 2 years old: Linzess is completely contraindicated — do not use under any circumstances.
- Children ages 2–6 with IBS-C: Linzess is not approved for IBS-C in this age group; it is only approved for functional constipation (FC) in children 2 and older.
- Known or suspected gut blockage: Do not take Linzess if you have or might have a mechanical obstruction in your intestines.
- Pregnancy: Linaclotide is barely absorbed into the bloodstream, so the risk to a developing baby is considered low — but there isn't enough human data to be certain. Talk to your doctor.
- Breastfeeding: Linaclotide was not detected in breast milk in studies. Your doctor can help weigh the benefits and any potential risks for your baby.
- Kidney or liver problems: Because linaclotide works inside the gut and is not significantly absorbed, kidney or liver impairment is not expected to change how the drug works or is cleared.
Linaclotide overdose
▾
In a clinical study where healthy volunteers received a single very large dose of Linzess, the most common reaction was diarrhea — consistent with what's seen at normal doses. If you or someone else takes too much, contact Poison Control or seek medical attention. The main concern would be diarrhea and resulting dehydration.
What Linaclotide does in the body
▾
Linzess works entirely inside the intestine — it is not meant to act on the rest of the body. By activating GC-C receptors on the gut lining, it increases fluid secretion into the intestinal space, which softens stool and speeds up how quickly things move through. Taking Linzess right after a high-fat meal leads to looser stools and more frequent bowel movements compared to taking it on an empty stomach — which is why the empty-stomach recommendation matters.
How your body processes Linaclotide
▾
Linaclotide is remarkably local in its action — it is minimally absorbed from the gut into the bloodstream. Blood levels after standard doses are so low they can't even be measured with standard lab tools. It is broken down within the intestine itself into smaller peptides and naturally occurring amino acids, and a small amount passes out in the stool. Because it stays in the gut, kidney or liver disease doesn't affect how it's processed, and it doesn't interact with the liver enzymes that metabolize most other drugs.
How to store Linaclotide
▾
Store at 25°C (77°F); excursions permitted between 15°C and 30°C (59°F and 86°F) . Protect from moisture.
Written from the FDA-approved label with AI and reviewed by our pharmacy team. How we use AI →
Supplements & herbs that interact with Linaclotide
17 supplements and herbal products have documented interactions with Linaclotide in the licensed clinical database we use. Most are manageable — but your pharmacist should know about everything you take, including vitamins and herbals.
- Major · 1
- Moderate · 7
- Minor · 9
Educational information from a licensed clinical database (Natural Medicines) — see our data sources & update cadence. Not medical advice: an interaction being documented does not mean it will happen to you; do not start or stop medications or supplements without professional guidance.
Linaclotide: pharmacist answers to common questions
Quick, plain-English answers to the questions patients ask most about Linaclotide — the kind of thing our pharmacy team would talk through with you at the counter.
What exactly does Linzess do — how is it different from a regular laxative?
▾
When should I take it, and does it matter if I eat first?
▾
Diarrhea is listed as a side effect — is that just ironic, or is it a real concern?
▾
I have trouble swallowing capsules — do I have to swallow Linzess whole?
▾
Is it safe for my child to take Linzess?
▾
Can I take Linzess if I'm pregnant or breastfeeding?
▾
Is Linaclotide available over the counter?
▾
When was Linaclotide first available?
▾
Answers drafted from the FDA-approved label with AI and reviewed by our pharmacy team. How we use AI →
More about Linaclotide on HelloPharmacist
Linaclotide forms and strengths (how it comes)
Linaclotide is available in 1 form. Different forms and brands can have different approved uses, doses, schedules, and directions. Follow the instructions for your exact product, and do not switch forms without guidance from your prescriber or pharmacist.
Need a version that does not list lactose, a gluten source, a dye or gelatin? Inactive ingredients differ by manufacturer: see Linaclotide inactive ingredients by manufacturer.
Capsule
How this form is used
- Linzess capsules are used to treat irritable bowel syndrome with constipation (IBS-C) in adults and children 7 years and older
- Linzess capsules are used to treat chronic idiopathic constipation (CIC) in adults
- Linzess capsules are used to treat functional constipation (FC) in children 2 years of age and older
- Linzess should be taken once daily on an empty stomach, at least 30 minutes before the first meal of the day
- Linzess capsules should be swallowed whole — do not crush or chew the capsule or its contents
- If you cannot swallow the capsule whole, Linzess beads can be opened and mixed with a teaspoon of room-temperature applesauce or about 30 mL of water and swallowed immediately — do not store the mixture for later
- Linzess can also be given via a nasogastric or gastrostomy tube using water — follow the full prescribing instructions for this method
Linaclotide on the U.S. market: products, makers and brands
How Linaclotide appears in the FDA’s National Drug Code Directory — including its dosage forms, strengths, brand names, manufacturers, and FDA-listed product records. These are directory records, not sales or prescription volume.
1 company lists 3 Linaclotide product records with the FDA, mostly as capsule; the earliest marketing or approval year on record is 2012. Brand names on the directory include Linzess; the rest are generics.
Also listed with the FDA, not a patient dose form: Powder (8) — bulk drug substance sold to compounders/manufacturers and multi-item kits. These aren’t counted in the dose-form total above.
How widely Linaclotide is used (Medicaid data)
A general measure of how commonly Linaclotide is prescribed, based on Medicaid — one of the largest public drug programs. The figure below is prescriptions filled in Q2 2025 – Q1 2026, summed across every form and brand of the drug.
Think of this as a proxy for how widely Linaclotide is used, drawn from freely available public data. Medicaid is just one program — these numbers don’t include Medicare, other government coverage, or commercial and cash-pay prescriptions, so real-world use is higher than what’s shown here.
How commonly is Linaclotide prescribed? Of the 1,601 medications we measure, Linaclotide ranks #185 by Medicaid prescriptions — more than 88% of them.
Utilization by Linaclotide product
Pick a product to see its own Medicaid numbers. Each chip is one clinical product — a specific strength & dosage form as defined by RxNorm — with brand-name and generic versions combined.
linaclotide 0.145 MG Oral Capsule Most dispensed
Summed across the 1 of 3 listed NDC products with Medicaid activity — every brand and generic of this exact strength & form. RxNorm 1307409
linaclotide 0.29 MG Oral Capsule
Summed across the 1 of 3 listed NDC products with Medicaid activity — every brand and generic of this exact strength & form. RxNorm 1307419
linaclotide 0.072 MG Oral Capsule
Summed across the 1 of 3 listed NDC products with Medicaid activity — every brand and generic of this exact strength & form. RxNorm 1869697
Shares are of the Medicaid prescriptions shown here. Product grouping follows RxNorm (the National Library of Medicine’s drug terminology), so “one product” means one strength & dosage form regardless of manufacturer. Dollar figures are gross Medicaid reimbursement before mandatory rebates — rebates (often large, especially for brand-name drugs) are confidential, so actual net cost to Medicaid is lower than shown.
Source: Medicaid State Drug Utilization Data (CMS), aggregated by generic ingredient — summed across every NDC (all brands, strengths, salt forms and dosage forms) of Linaclotide, and across all states and both fee-for-service and managed-care claims. A general popularity signal; it excludes Medicare, commercial insurance and cash prescriptions, so it is not total U.S. use. Based on the 3 of 9 listed Linaclotide NDCs with Medicaid activity.
Compare Linaclotide products
A representative set of FDA-listed product records for Linaclotide — across manufacturers, strengths, and dosage forms, grouped by form with each product’s manufacturer and how the FDA approved it. The same medicine may be made and packaged by different companies, so a single drug can have many directory entries. (It’s also why a refill can look different — a new shape, color, or box — even though it contains the same medication.)
| Strength | Route | Manufacturer / Labeler | Category ⓘ | Details |
|---|---|---|---|---|
| 💊Capsule | ||||
| 72 mcg | Oral | Allergan, Inc. | NDA | View NDC → |
| 145 mcg | Oral | Allergan, Inc. | NDA | View NDC → |
| 290 mcg | Oral | Allergan, Inc. | NDA | View NDC → |
Showing 3 of 3 products — FDA National Drug Code Directory. See every product, package size and price: browse all 3 Linaclotide NDCs →
Linaclotide side effects reported to the FDA (FAERS)
After a medicine reaches the market, patients, doctors and drugmakers can send the FDA reports of problems they think may be linked to it. Here’s what’s been reported for Linaclotide — a signal of what to watch for, not proof the drug caused it.
The effects most often named in FDA reports that mention Linaclotide are diarrhoea, constipation, nausea; about 36% of the reports were classed as serious. These are voluntary reports, so they show what people report, not how often it happens.
Source: openFDA, from the FDA Adverse Event Reporting System (FAERS). These are voluntary reports — they don’t prove the drug caused the effect, and counts reflect how often something was reported, not how often it actually happens. Reports also often name the very problem the medicine is taken for — a common reason to file one is that the drug didn’t help — so for a pain reliever you may see “pain” high on the list; that points to why the report was filed, not to the drug causing the symptom. This counts every report that lists Linaclotide in any role, so the total runs higher than the FDA’s official dashboard, which counts only cases where the drug is the suspect. For the authoritative figures, see the FDA FAERS Public Dashboard. Always talk to your pharmacist or doctor.
Linaclotide FDA approval history
How Linaclotide went from FDA review to the pharmacy shelf — the key milestones in its regulatory journey.
Linaclotide was first approved by the FDA in 2012 (Brand: LINZESS · Abbvie); the first generic version was approved in 2021. It remains available in U.S. pharmacies today.
Source: Drugs@FDA.
Linaclotide recall history
A recall is when a specific batch of a medicine is pulled from the market — usually a manufacturing issue, not a problem with the drug itself. Class I is most serious, Class III least.
The FDA’s enforcement reports list no Linaclotide recalls since July 2021.
✅No Linaclotide recalls on record since July 2021Source: FDA enforcement (recall) reports, via openFDA; our copy was last updated Sep 24, 2026.
RxNorm Concept Web — From Ingredient to Every Form and Strength
This page starts with one ingredient concept (IN). The branches below show its dose-form concepts (SCDF), then the available clinical drug and strength concepts (SCD). Combination products remain separate concepts with their own pages.
RxCUI 1307404 1 dose form · 3 strengths
-
Dose form (SCDF) Oral Capsule RxCUI 1307408In current FDA listings
Look up RxCUI 1307404 in the RxCUI Atlas →
RxNorm is the U.S. National Library of Medicine’s normalized drug vocabulary. Its concept hierarchy can include forms that are not currently marketed; the status on each branch compares that concept with current FDA listings. RxCUIs identify vocabulary concepts, not individual packages or manufacturers.
Linaclotide supply and shortage status
Whether Linaclotide is in short supply in the U.S. right now, plus any shortage history the FDA has on record. A shortage usually reflects a manufacturing or demand issue — not a safety problem with the drug.
Source: openFDA, from the FDA Drug Shortages database.
💵 What Linaclotide costs pharmacies (NADAC benchmark)
The national average invoice price pharmacies pay for the drug itself, from CMS's NADAC survey (data as of Sep 30, 2026). This is a supply-cost benchmark — not a retail price and not what you'd pay at the counter.
| Form | Strength | Pharmacy acquisition benchmark | |
|---|---|---|---|
| Capsule, Gelatin Coated · Oral | 145 mcg | $9.02 per capsule | NDC details & price history |
| Capsule, Gelatin Coated · Oral | 290 mcg | $9.02 per capsule | NDC details & price history |
| Capsule, Gelatin Coated · Oral | 72 mcg | $9.01 per capsule | NDC details & price history |
Source: CMS National Average Drug Acquisition Cost (NADAC), a survey of retail pharmacy invoice prices. Benchmarks shown are the range across package sizes of a representative product for each form and strength — other manufacturers' products may differ.
Linaclotide brand names
Linaclotide is sold under one brand name in the FDA directory — Linzess. A brand and its generic contain the same active ingredient; the brand name belongs to one company's product.
Who makes Linaclotide: manufacturers and labelers
One company lists Linaclotide products with the FDA. By number of product records, the largest are Allergan, Inc.. Labelers include manufacturers and repackagers; the product in your bottle depends on which one your pharmacy stocks.
Linaclotide drug class (RxNorm)
Linaclotide belongs to the Guanylate Cyclase-C Agonist class.
Classified by RxNorm RxClass — the U.S. National Library of Medicine's standardized drug-classification service (Established Pharmacologic Class from the FDA, the ATC drug family from the WHO, and mechanism of action). Reference only, not medical advice.
Sources for this Linaclotide page
Core label, product, RxNorm, safety, and utilization data on this page come from the sources identified below. AI-written, editorial, and licensed sections are labeled separately.
How this page is built
HelloPharmacist combines public FDA and NLM records and does not author the underlying clinical facts. The plain-language sections are written with AI from the FDA-approved label text and reviewed by our pharmacy team before publication. Allergan, Inc. is the representative DailyMed label linked for verification and dates. This is general education, not medical advice: always talk to your doctor or pharmacist about your own medicines. How we build and review drug pages →